> top > docs > PMC:7293470 > annotations

PMC:7293470 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PMC-OGER-BB

Id Subject Object Predicate Lexical cue
T1 34-42 SP_7 denotes COVID-19
T2 77-88 NCBITaxon:1 denotes individuals
T3 111-119 SP_7 denotes COVID-19
T4 121-131 SP_7 denotes SARS-CoV-2
T5 260-264 GO:0016265 denotes died
T6 292-303 UBERON:0001004 denotes respiratory
T7 340-345 UBERON:0000062 denotes organ
T8 358-363 GO:0016265 denotes death
T9 445-451 GO:0045087 denotes innate
T10 456-464 GO:0045087 denotes adaptive
T11 465-471 GO:0045087;UBERON:0002405 denotes immune
T12 544-548 UBERON:0002048 denotes lung
T13 549-557 UBERON:0002299 denotes alveolar
T14 558-569 UBERON:0001986 denotes endothelium
T15 631-636 UBERON:0000948 denotes heart
T16 638-643 UBERON:0002107 denotes liver
T17 648-655 UBERON:0002113 denotes kidneys
T18 726-734 SP_7 denotes COVID-19
T19 787-798 UBERON:0001004 denotes respiratory
T20 809-813 SP_10 denotes SARS
T21 828-839 UBERON:0001004 denotes respiratory
T22 925-929 G_3;PG_10;PR:000003622 denotes ACE2
T23 931-962 PG_10;PR:000003622 denotes angiotensin-converting enzyme-2
T24 1004-1014 SP_7 denotes SARS-CoV-2
T25 1015-1020 NCBITaxon:10239 denotes virus
T26 1029-1037 UBERON:0003215;CL:0000322 denotes alveolar
T27 1038-1048 CL:0000322;UBERON:0000483 denotes epithelial
T28 1049-1054 CL:0000322 denotes cells
T29 1071-1089 GO:0006956 denotes complement cascade
T30 1103-1109 CHEBI:5054;CHEBI:5054 denotes fibrin
T31 1132-1140 CL:0000233;GO:0070527 denotes platelet
T32 1141-1152 GO:0070527 denotes aggregation
T33 1157-1167 CL:0000235;GO:0042116 denotes macrophage
T34 1168-1178 GO:0042116 denotes activation
T35 1192-1201 GO:0008152 denotes metabolic
T36 1213-1229 CHEBI:15843;CHEBI:15843 denotes arachidonic acid
T37 1235-1245 GO:0050663 denotes release of
T38 1246-1260 CHEBI:15627;CHEBI:15627 denotes thromboxane A2
T39 1278-1283 PR:000001136 denotes IL-1β
T40 1285-1289 PR:000001393 denotes IL-6
T41 1291-1296 PR:000000134 denotes TNF-α
T42 1298-1306 CL:0000233;GO:0030168;CHEBI:44811;CHEBI:44811 denotes platelet
T43 1307-1317 GO:0030168;CHEBI:44811;CHEBI:44811 denotes activating
T44 1318-1324 CHEBI:44811;CHEBI:44811 denotes factor
T45 1327-1339 CHEBI:16480;CHEBI:16480 denotes nitric oxide
T46 1371-1381 CL:0000775;GO:0042119 denotes neutrophil
T47 1382-1392 GO:0042119 denotes activation
T48 1440-1442 CHEBI:15379;CHEBI:15379 denotes O2
T49 1443-1451 CHEBI:26519;CHEBI:26519 denotes radicals
T50 1470-1474 PR:000001200 denotes CCR4
T51 1475-1479 PR:000001202 denotes CCR6
T52 1485-1500 GO:0001775 denotes cell activation
T53 1525-1529 PR:000001317 denotes IL-7
T54 1531-1536 PR:000000017 denotes IFN-γ
T55 1538-1543 PR:000005932 denotes G-CSF
T56 1559-1563 PR:000002122 denotes CCL2
T57 1565-1569 PR:000002123 denotes CCL3
T58 1644-1649 UBERON:0000170 denotes lungs
T59 1665-1676 UBERON:0001986 denotes endothelial
T60 1688-1699 UBERON:0001004 denotes respiratory
T61 1718-1722 G_3;PG_10;PR:000003622 denotes ACE2
T62 1726-1735 GO:0010467 denotes expressed
T63 1739-1744 UBERON:0000948 denotes heart
T64 1746-1751 UBERON:0002107 denotes liver
T65 1756-1762 UBERON:0002113;CL:1000497 denotes kidney
T66 1763-1768 CL:1000497 denotes cells
T67 1818-1828 SP_7 denotes SARS-CoV-2
T68 1853-1858 UBERON:0000062 denotes organ
T69 1910-1925 CHEBI:24261;CHEBI:24261 denotes glucocorticoids
T70 1948-1956 SP_7 denotes COVID-19
T71 1986-1990 CHEBI:23888;CHEBI:23888 denotes drug
T72 2090-2105 CHEBI:52217;CHEBI:52217 denotes pharmacological
T73 2106-2111 CHEBI:23888;CHEBI:23888 denotes drugs
T74 2177-2186 UBERON:0002048 denotes pulmonary
T75 2254-2260 UBERON:0001005 denotes airway
T76 2261-2274 UBERON:0001135 denotes smooth muscle
T77 2292-2302 CHEBI:7034;CHEBI:7034 denotes muscarinic
T78 2303-2323 CHEBI:48561;CHEBI:48561 denotes receptor antagonists
T79 2368-2372 CHEBI:23888;CHEBI:23888 denotes drug
T80 2420-2428 CL:0000233;GO:0030168;CHEBI:44811;CHEBI:44811 denotes platelet
T81 2428-2439 GO:0030168;CHEBI:44811;CHEBI:44811 denotes -activating
T82 2440-2446 CHEBI:44811;CHEBI:44811 denotes factor
T83 2451-2460 CHEBI:18295;CHEBI:18295 denotes histamine
T84 2466-2475 CL:0000097 denotes mast cell
T85 2512-2534 CHEBI:35472;CHEBI:35472 denotes anti-inflammatory drug
T86 2566-2577 CHEBI:26995;CHEBI:26995 denotes thromboxane
T87 2601-2612 CHEBI:49159;CHEBI:49159 denotes leukotriene
T88 2639-2647 CHEBI:36357;CHEBI:36357 denotes molecule
T89 2664-2672 GO:0042571 denotes antibody
T90 2706-2710 PR:000001391 denotes IL-4
T91 2715-2720 PR:000001370 denotes IL-13
T92 2735-2739 PR:000001391 denotes IL-4
T93 2758-2763 UBERON:0001977 denotes serum
T94 2788-2794 UBERON:0001005 denotes airway
T95 2816-2820 UBERON:0002048 denotes lung
T96 2841-2845 SO:0000704;GO:0010467 denotes gene
T97 2846-2856 GO:0010467 denotes expression
T98 2861-2866 UBERON:0001977 denotes serum
T99 2890-2894 NCBITaxon:10088 denotes mice
T100 2904-2908 UBERON:0001638 denotes vein
T101 3010-3018 SP_7 denotes COVID-19
T102 3054-3059 GO:0016265 denotes death
T103 3125-3130 PR:000001136 denotes IL-1β
T104 3132-3137 PR:000000134 denotes TNF-α
T105 3139-3143 PR:000001393 denotes IL-6
T106 3148-3152 PR:000001379 denotes IL-2
T107 3182-3192 CL:0000235;PR:000010413;GO:0042116 denotes macrophage
T108 3193-3202 PR:000010413;GO:0042116 denotes migration
T109 3214-3220 PR:000010413 denotes factor
T110 3235-3242 SO:0000853 denotes homolog
T111 3243-3247 PR:P11914 denotes MIF2
T112 3256-3260 PR:000001822 denotes CD74
T113 3277-3282 PR:000001257 denotes CXCR2
T114 3311-3321 CHEBI:35222;CHEBI:35222 denotes inhibitors
T115 3460-3464 CHEBI:23888;CHEBI:23888 denotes drug
T116 3538-3542 PR:000001822 denotes CD74
T117 3615-3618 PR:000029150 denotes HLA
T118 3624-3630 SO:0000417 denotes domain
T119 3701-3705 PR:000001822 denotes CD74
T120 3741-3747 CL:0000218;UBERON:0000345 denotes myelin
T121 3748-3769 CL:0000128 denotes oligodendroglial cell
T122 3770-3782 PR:000037069;CHEBI:17089;BV_11;CHEBI:17089 denotes glycoprotein
T123 3789-3792 PR:000010514 denotes MOG
T124 3849-3861 GO:0042613 denotes MHC Class II
T125 3862-3863 PR:P0CY06 denotes α
T126 3868-3877 CHEBI:59132;CHEBI:59132 denotes antigenic
T127 3920-3926 GO:0006266 denotes ligate
T128 3936-3942 CL:0000084 denotes T cell
T129 3998-4005 GO:0032991 denotes complex
T130 4127-4130 GO:0042611 denotes MHC
T131 4135-4144 CHEBI:59132;CHEBI:59132 denotes antigenic
T132 4186-4189 GO:0042611 denotes MHC
T133 4201-4208 CHEBI:59132;CHEBI:59132 denotes antigen
T134 4218-4225 CL:0000084 denotes T cells
T135 4231-4242 GO:0006412 denotes translation
T136 4258-4263 SP_6;NCBITaxon:9606 denotes human
T137 4339-4342 GO:0042611 denotes MHC
T138 4446-4451 SP_6;NCBITaxon:9606 denotes human
T139 4457-4463 SO:0000417 denotes domain
T140 4498-4504 SO:0000417 denotes domain
T141 4506-4512 MOP:0000779 denotes linked
T142 4635-4641 UBERON:0000479 denotes tissue
T143 4690-4693 PR:000010514 denotes MOG
T144 4768-4774 NCBITaxon:33208 denotes animal
T145 4813-4828 CHEBI:6809;CHEBI:6809 denotes methamphetamine
T146 4853-4858 UBERON:0000955 denotes brain
T147 5011-5017 GO:0045087 denotes innate
T148 5022-5030 GO:0002250 denotes adaptive
T149 5031-5037 GO:0002250;UBERON:0002405 denotes immune
T150 5038-5047 GO:0002250 denotes responses
T151 5076-5086 SP_7 denotes SARS-CoV-2
T152 5133-5138 PR:000001173 denotes C5aR1
T153 5140-5148 CL:0000233;GO:0030168 denotes platelet
T154 5149-5159 GO:0030168 denotes activation
T155 5161-5166 PR:000001136 denotes IL-1β
T156 5168-5172 PR:000001379 denotes IL-2
T157 5174-5178 PR:000001393 denotes IL-6
T158 5180-5185 PR:000000134 denotes TNF-α
T159 5187-5191 PR:000001199 denotes CCR2
T160 5206-5210 PR:000002122 denotes CCL2
T161 5216-5221 PR:000001257 denotes CXCR2
T162 5291-5300 CL:0002629 denotes activated
T163 5301-5308 CL:0002248;UBERON:0002048 denotes pleural
T164 5309-5315 CL:0000084 denotes T cell
T165 5347-5356 CHEBI:30501;CHEBI:30501 denotes beryllium
T166 5365-5369 UBERON:0002048 denotes lung
T167 5482-5490 SP_7 denotes COVID-19
T168 5591-5601 SP_7 denotes SARS-CoV-2
T169 5626-5630 CHEBI:23888;CHEBI:23888 denotes drug
T170 5648-5651 PR:000029150 denotes HLA
T171 5657-5663 SO:0000417 denotes domain
T172 5664-5681 MOP:0000779 denotes covalently linked
T173 5685-5690 SP_6;NCBITaxon:9606 denotes human
T174 5691-5697 UBERON:0000345 denotes myelin
T175 5698-5719 CL:0000128 denotes oligodendroglial cell
T176 5720-5732 CHEBI:17089;CHEBI:17089;PR:000037069;BV_11 denotes glycoprotein
T177 5734-5737 PR:000010514 denotes MOG
T178 5814-5820 CL:0000084 denotes T cell
T179 5839-5842 GO:0042611 denotes MHC
T180 5862-5866 PR:000001822 denotes CD74
T181 5920-5928 SO:0000853 denotes homologs
T182 5938-5942 PR:P11914 denotes MIF2
T183 6043-6049 SO:0000417 denotes domain
T200 6181-6191 CHEBI:35222;CHEBI:35222 denotes inhibitors
T201 6269-6277 SP_7 denotes COVID-19
T202 6392-6397 NCBITaxon:10239 denotes virus
T203 6426-6437 NCBITaxon:11118 denotes coronavirus
T204 6565-6575 GO:0065007 denotes regulatory
T205 6576-6582 UBERON:0002405 denotes immune
T206 6627-6635 SP_7 denotes COVID-19
T78946 34-42 SP_7 denotes COVID-19
T65084 77-88 NCBITaxon:1 denotes individuals
T81248 111-119 SP_7 denotes COVID-19
T26403 121-131 SP_7 denotes SARS-CoV-2
T92715 260-264 GO:0016265 denotes died
T84467 292-303 UBERON:0001004 denotes respiratory
T35381 340-345 UBERON:0000062 denotes organ
T53090 358-363 GO:0016265 denotes death
T88015 445-451 GO:0045087 denotes innate
T28316 456-464 GO:0045087 denotes adaptive
T50481 465-471 GO:0045087;UBERON:0002405 denotes immune
T34283 544-548 UBERON:0002048 denotes lung
T57168 549-557 UBERON:0002299 denotes alveolar
T18489 558-569 UBERON:0001986 denotes endothelium
T53396 631-636 UBERON:0000948 denotes heart
T54590 638-643 UBERON:0002107 denotes liver
T20185 648-655 UBERON:0002113 denotes kidneys
T39846 726-734 SP_7 denotes COVID-19
T1106 787-798 UBERON:0001004 denotes respiratory
T1053 809-813 SP_10 denotes SARS
T34245 828-839 UBERON:0001004 denotes respiratory
T80027 925-929 G_3;PG_10;PR:000003622 denotes ACE2
T45715 931-962 PG_10;PR:000003622 denotes angiotensin-converting enzyme-2
T19801 1004-1014 SP_7 denotes SARS-CoV-2
T74447 1015-1020 NCBITaxon:10239 denotes virus
T25830 3139-3143 PR:000001393 denotes IL-6
T36584 1029-1037 UBERON:0003215;CL:0000322 denotes alveolar
T37706 1038-1048 CL:0000322;UBERON:0000483 denotes epithelial
T6880 1049-1054 CL:0000322 denotes cells
T64972 1071-1089 GO:0006956 denotes complement cascade
T80119 1103-1109 CHEBI:5054;CHEBI:5054 denotes fibrin
T89105 1132-1140 CL:0000233;GO:0070527 denotes platelet
T46204 1141-1152 GO:0070527 denotes aggregation
T89021 1157-1167 CL:0000235;GO:0042116 denotes macrophage
T50399 1168-1178 GO:0042116 denotes activation
T21431 1192-1201 GO:0008152 denotes metabolic
T44281 1213-1229 CHEBI:15843;CHEBI:15843 denotes arachidonic acid
T31389 1235-1245 GO:0050663 denotes release of
T26206 1246-1260 CHEBI:15627;CHEBI:15627 denotes thromboxane A2
T45137 1278-1283 PR:000001136 denotes IL-1β
T74627 1285-1289 PR:000001393 denotes IL-6
T99507 1291-1296 PR:000000134 denotes TNF-α
T4921 1298-1306 CL:0000233;GO:0030168;CHEBI:44811;CHEBI:44811 denotes platelet
T84791 1307-1317 GO:0030168;CHEBI:44811;CHEBI:44811 denotes activating
T97723 1318-1324 CHEBI:44811;CHEBI:44811 denotes factor
T77635 1327-1339 CHEBI:16480;CHEBI:16480 denotes nitric oxide
T47491 1371-1381 CL:0000775;GO:0042119 denotes neutrophil
T96398 1382-1392 GO:0042119 denotes activation
T3232 1440-1442 CHEBI:15379;CHEBI:15379 denotes O2
T48972 1443-1451 CHEBI:26519;CHEBI:26519 denotes radicals
T95595 1470-1474 PR:000001200 denotes CCR4
T11457 1475-1479 PR:000001202 denotes CCR6
T84194 1485-1500 GO:0001775 denotes cell activation
T19961 1525-1529 PR:000001317 denotes IL-7
T15211 1531-1536 PR:000000017 denotes IFN-γ
T81249 1538-1543 PR:000005932 denotes G-CSF
T96017 1559-1563 PR:000002122 denotes CCL2
T98565 1565-1569 PR:000002123 denotes CCL3
T69580 1644-1649 UBERON:0000170 denotes lungs
T8108 1665-1676 UBERON:0001986 denotes endothelial
T17411 1688-1699 UBERON:0001004 denotes respiratory
T51882 1718-1722 G_3;PG_10;PR:000003622 denotes ACE2
T87066 1726-1735 GO:0010467 denotes expressed
T81756 1739-1744 UBERON:0000948 denotes heart
T36304 1746-1751 UBERON:0002107 denotes liver
T25334 1756-1762 UBERON:0002113;CL:1000497 denotes kidney
T15348 1763-1768 CL:1000497 denotes cells
T12505 1818-1828 SP_7 denotes SARS-CoV-2
T88611 1853-1858 UBERON:0000062 denotes organ
T60848 1910-1925 CHEBI:24261;CHEBI:24261 denotes glucocorticoids
T95231 1948-1956 SP_7 denotes COVID-19
T65747 1986-1990 CHEBI:23888;CHEBI:23888 denotes drug
T49829 2090-2105 CHEBI:52217;CHEBI:52217 denotes pharmacological
T6948 2106-2111 CHEBI:23888;CHEBI:23888 denotes drugs
T52070 2177-2186 UBERON:0002048 denotes pulmonary
T37965 2254-2260 UBERON:0001005 denotes airway
T82075 2261-2274 UBERON:0001135 denotes smooth muscle
T68520 2292-2302 CHEBI:7034;CHEBI:7034 denotes muscarinic
T83831 2303-2323 CHEBI:48561;CHEBI:48561 denotes receptor antagonists
T70978 2368-2372 CHEBI:23888;CHEBI:23888 denotes drug
T2252 2420-2428 CL:0000233;GO:0030168;CHEBI:44811;CHEBI:44811 denotes platelet
T56269 2428-2439 GO:0030168;CHEBI:44811;CHEBI:44811 denotes -activating
T88762 2440-2446 CHEBI:44811;CHEBI:44811 denotes factor
T44552 2451-2460 CHEBI:18295;CHEBI:18295 denotes histamine
T96679 2466-2475 CL:0000097 denotes mast cell
T70624 2512-2534 CHEBI:35472;CHEBI:35472 denotes anti-inflammatory drug
T40591 2566-2577 CHEBI:26995;CHEBI:26995 denotes thromboxane
T26436 2601-2612 CHEBI:49159;CHEBI:49159 denotes leukotriene
T36736 2639-2647 CHEBI:36357;CHEBI:36357 denotes molecule
T93139 2664-2672 GO:0042571 denotes antibody
T20922 2706-2710 PR:000001391 denotes IL-4
T14132 2715-2720 PR:000001370 denotes IL-13
T866 2735-2739 PR:000001391 denotes IL-4
T67645 2758-2763 UBERON:0001977 denotes serum
T49861 2788-2794 UBERON:0001005 denotes airway
T290 2816-2820 UBERON:0002048 denotes lung
T6036 2841-2845 SO:0000704;GO:0010467 denotes gene
T62989 2846-2856 GO:0010467 denotes expression
T5551 2861-2866 UBERON:0001977 denotes serum
T64215 2890-2894 NCBITaxon:10088 denotes mice
T47575 2904-2908 UBERON:0001638 denotes vein
T51817 3010-3018 SP_7 denotes COVID-19
T1627 3054-3059 GO:0016265 denotes death
T71744 3125-3130 PR:000001136 denotes IL-1β
T72874 3132-3137 PR:000000134 denotes TNF-α
T50374 3148-3152 PR:000001379 denotes IL-2
T81675 3182-3192 CL:0000235;PR:000010413;GO:0042116 denotes macrophage
T30336 3193-3202 PR:000010413;GO:0042116 denotes migration
T28390 3214-3220 PR:000010413 denotes factor
T86655 3235-3242 SO:0000853 denotes homolog
T67518 3243-3247 PR:P11914 denotes MIF2
T13748 3256-3260 PR:000001822 denotes CD74
T20136 3277-3282 PR:000001257 denotes CXCR2
T16871 3311-3321 CHEBI:35222;CHEBI:35222 denotes inhibitors
T51111 3460-3464 CHEBI:23888;CHEBI:23888 denotes drug
T81051 3538-3542 PR:000001822 denotes CD74
T22349 3615-3618 PR:000029150 denotes HLA
T63661 3624-3630 SO:0000417 denotes domain
T30295 3701-3705 PR:000001822 denotes CD74
T18138 3741-3747 CL:0000218;UBERON:0000345 denotes myelin
T44160 3748-3769 CL:0000128 denotes oligodendroglial cell
T56256 3770-3782 PR:000037069;CHEBI:17089;BV_11;CHEBI:17089 denotes glycoprotein
T52727 3789-3792 PR:000010514 denotes MOG
T81970 3849-3861 GO:0042613 denotes MHC Class II
T83534 3862-3863 PR:P0CY06 denotes α
T67777 3868-3877 CHEBI:59132;CHEBI:59132 denotes antigenic
T72943 3920-3926 GO:0006266 denotes ligate
T16068 3936-3942 CL:0000084 denotes T cell
T82716 3998-4005 GO:0032991 denotes complex
T28841 4127-4130 GO:0042611 denotes MHC
T93931 4135-4144 CHEBI:59132;CHEBI:59132 denotes antigenic
T69769 4186-4189 GO:0042611 denotes MHC
T81989 4201-4208 CHEBI:59132;CHEBI:59132 denotes antigen
T41673 4218-4225 CL:0000084 denotes T cells
T85672 4231-4242 GO:0006412 denotes translation
T81660 4258-4263 SP_6;NCBITaxon:9606 denotes human
T64396 4339-4342 GO:0042611 denotes MHC
T74610 4446-4451 SP_6;NCBITaxon:9606 denotes human
T78710 4457-4463 SO:0000417 denotes domain
T50125 4498-4504 SO:0000417 denotes domain
T69070 4506-4512 MOP:0000779 denotes linked
T53267 4635-4641 UBERON:0000479 denotes tissue
T15961 4690-4693 PR:000010514 denotes MOG
T98332 4768-4774 NCBITaxon:33208 denotes animal
T91272 4813-4828 CHEBI:6809;CHEBI:6809 denotes methamphetamine
T78478 4853-4858 UBERON:0000955 denotes brain
T66311 5011-5017 GO:0045087 denotes innate
T89429 5022-5030 GO:0002250 denotes adaptive
T83884 5031-5037 GO:0002250;UBERON:0002405 denotes immune
T58055 5038-5047 GO:0002250 denotes responses
T11954 5076-5086 SP_7 denotes SARS-CoV-2
T41665 5133-5138 PR:000001173 denotes C5aR1
T18310 5140-5148 CL:0000233;GO:0030168 denotes platelet
T71710 5149-5159 GO:0030168 denotes activation
T92918 5161-5166 PR:000001136 denotes IL-1β
T94394 5168-5172 PR:000001379 denotes IL-2
T78460 5174-5178 PR:000001393 denotes IL-6
T88059 5180-5185 PR:000000134 denotes TNF-α
T99547 5187-5191 PR:000001199 denotes CCR2
T8821 5206-5210 PR:000002122 denotes CCL2
T8352 5216-5221 PR:000001257 denotes CXCR2
T50176 5291-5300 CL:0002629 denotes activated
T96883 5301-5308 CL:0002248;UBERON:0002048 denotes pleural
T20532 5309-5315 CL:0000084 denotes T cell
T96822 5347-5356 CHEBI:30501;CHEBI:30501 denotes beryllium
T17438 5365-5369 UBERON:0002048 denotes lung
T18732 5482-5490 SP_7 denotes COVID-19
T35466 5591-5601 SP_7 denotes SARS-CoV-2
T93107 5626-5630 CHEBI:23888;CHEBI:23888 denotes drug
T51669 5648-5651 PR:000029150 denotes HLA
T21336 5657-5663 SO:0000417 denotes domain
T8587 5664-5681 MOP:0000779 denotes covalently linked
T89061 5685-5690 SP_6;NCBITaxon:9606 denotes human
T84719 5691-5697 UBERON:0000345 denotes myelin
T35539 5698-5719 CL:0000128 denotes oligodendroglial cell
T48954 5720-5732 CHEBI:17089;CHEBI:17089;PR:000037069;BV_11 denotes glycoprotein
T10720 5734-5737 PR:000010514 denotes MOG
T14874 5814-5820 CL:0000084 denotes T cell
T62496 5839-5842 GO:0042611 denotes MHC
T5107 5862-5866 PR:000001822 denotes CD74
T21593 5920-5928 SO:0000853 denotes homologs
T530 5938-5942 PR:P11914 denotes MIF2
T28730 6043-6049 SO:0000417 denotes domain
T34093 6181-6191 CHEBI:35222;CHEBI:35222 denotes inhibitors
T28735 6269-6277 SP_7 denotes COVID-19
T25144 6392-6397 NCBITaxon:10239 denotes virus
T84484 6426-6437 NCBITaxon:11118 denotes coronavirus
T86556 6565-6575 GO:0065007 denotes regulatory
T66367 6576-6582 UBERON:0002405 denotes immune
T92453 6627-6635 SP_7 denotes COVID-19

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T1 340-345 Body_part denotes organ http://purl.org/sig/ont/fma/fma67498
T2 496-504 Body_part denotes cytokine http://purl.org/sig/ont/fma/fma84050
T3 544-548 Body_part denotes lung http://purl.org/sig/ont/fma/fma7195
T4 549-557 Body_part denotes alveolar http://purl.org/sig/ont/fma/fma264783
T5 558-569 Body_part denotes endothelium http://purl.org/sig/ont/fma/fma63916
T6 631-636 Body_part denotes heart http://purl.org/sig/ont/fma/fma7088
T7 638-643 Body_part denotes liver http://purl.org/sig/ont/fma/fma7197
T8 648-655 Body_part denotes kidneys http://purl.org/sig/ont/fma/fma7203
T9 991-998 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T10 1029-1054 Body_part denotes alveolar epithelial cells http://purl.org/sig/ont/fma/fma62499
T11 1049-1054 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T12 1132-1140 Body_part denotes platelet http://purl.org/sig/ont/fma/fma62851
T13 1157-1167 Body_part denotes macrophage http://purl.org/sig/ont/fma/fma63261
T14 1258-1260 Body_part denotes A2 http://purl.org/sig/ont/fma/fma66595
T15 1278-1282 Body_part denotes IL-1 http://purl.org/sig/ont/fma/fma86583
T16 1298-1306 Body_part denotes platelet http://purl.org/sig/ont/fma/fma62851
T17 1371-1381 Body_part denotes neutrophil http://purl.org/sig/ont/fma/fma62860
T18 1485-1489 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T19 1519-1523 Body_part denotes IL-2 http://purl.org/sig/ont/fma/fma84051
T20 1540-1543 Body_part denotes CSF http://purl.org/sig/ont/fma/fma20935
T21 1548-1558 Body_part denotes chemokines http://purl.org/sig/ont/fma/fma241981
T22 1644-1649 Body_part denotes lungs http://purl.org/sig/ont/fma/fma68877
T23 1739-1744 Body_part denotes heart http://purl.org/sig/ont/fma/fma7088
T24 1746-1751 Body_part denotes liver http://purl.org/sig/ont/fma/fma7197
T25 1756-1762 Body_part denotes kidney http://purl.org/sig/ont/fma/fma7203
T26 1763-1768 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T27 1853-1858 Body_part denotes organ http://purl.org/sig/ont/fma/fma67498
T28 2268-2274 Body_part denotes muscle http://purl.org/sig/ont/fma/fma32558
T29 2420-2428 Body_part denotes platelet http://purl.org/sig/ont/fma/fma62851
T30 2451-2460 Body_part denotes histamine http://purl.org/sig/ont/fma/fma61806
T31 2466-2475 Body_part denotes mast cell http://purl.org/sig/ont/fma/fma66784
T32 2471-2475 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T33 2664-2672 Body_part denotes antibody http://purl.org/sig/ont/fma/fma62871
T34 2758-2763 Body_part denotes serum http://purl.org/sig/ont/fma/fma63083
T35 2764-2767 Body_part denotes IgE http://purl.org/sig/ont/fma/fma62875
T36 2816-2820 Body_part denotes lung http://purl.org/sig/ont/fma/fma7195
T37 2841-2845 Body_part denotes gene http://purl.org/sig/ont/fma/fma74402
T38 2861-2866 Body_part denotes serum http://purl.org/sig/ont/fma/fma63083
T39 2904-2908 Body_part denotes vein http://purl.org/sig/ont/fma/fma50723
T40 2992-3000 Body_part denotes cytokine http://purl.org/sig/ont/fma/fma84050
T41 3125-3129 Body_part denotes IL-1 http://purl.org/sig/ont/fma/fma86583
T42 3148-3152 Body_part denotes IL-2 http://purl.org/sig/ont/fma/fma84051
T43 3182-3192 Body_part denotes macrophage http://purl.org/sig/ont/fma/fma63261
T44 3325-3333 Body_part denotes cytokine http://purl.org/sig/ont/fma/fma84050
T45 3615-3618 Body_part denotes HLA http://purl.org/sig/ont/fma/fma84795
T46 3644-3654 Body_part denotes amino acid http://purl.org/sig/ont/fma/fma82739
T47 3741-3747 Body_part denotes myelin http://purl.org/sig/ont/fma/fma62977
T48 3748-3769 Body_part denotes oligodendroglial cell http://purl.org/sig/ont/fma/fma54540
T49 3765-3769 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T50 3770-3782 Body_part denotes glycoprotein http://purl.org/sig/ont/fma/fma62925
T51 3849-3852 Body_part denotes MHC http://purl.org/sig/ont/fma/fma84079
T52 3938-3942 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T53 4127-4130 Body_part denotes MHC http://purl.org/sig/ont/fma/fma84079
T54 4186-4189 Body_part denotes MHC http://purl.org/sig/ont/fma/fma84079
T55 4220-4225 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T56 4339-4342 Body_part denotes MHC http://purl.org/sig/ont/fma/fma84079
T57 4489-4492 Body_part denotes HLA http://purl.org/sig/ont/fma/fma84795
T58 4635-4641 Body_part denotes tissue http://purl.org/sig/ont/fma/fma9637
T59 4853-4858 Body_part denotes brain http://purl.org/sig/ont/fma/fma50801
T60 5087-5095 Body_part denotes cytokine http://purl.org/sig/ont/fma/fma84050
T61 5140-5148 Body_part denotes platelet http://purl.org/sig/ont/fma/fma62851
T62 5161-5165 Body_part denotes IL-1 http://purl.org/sig/ont/fma/fma86583
T63 5168-5172 Body_part denotes IL-2 http://purl.org/sig/ont/fma/fma84051
T64 5256-5259 Body_part denotes HLA http://purl.org/sig/ont/fma/fma84795
T65 5311-5315 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T66 5365-5369 Body_part denotes lung http://purl.org/sig/ont/fma/fma7195
T67 5564-5572 Body_part denotes Cytokine http://purl.org/sig/ont/fma/fma84050
T68 5648-5651 Body_part denotes HLA http://purl.org/sig/ont/fma/fma84795
T69 5691-5697 Body_part denotes myelin http://purl.org/sig/ont/fma/fma62977
T70 5698-5719 Body_part denotes oligodendroglial cell http://purl.org/sig/ont/fma/fma54540
T71 5715-5719 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T72 5720-5732 Body_part denotes glycoprotein http://purl.org/sig/ont/fma/fma62925
T73 5816-5820 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T74 5839-5842 Body_part denotes MHC http://purl.org/sig/ont/fma/fma84079
T75 5998-6006 Body_part denotes Cytokine http://purl.org/sig/ont/fma/fma84050
T76 6166-6174 Body_part denotes cytokine http://purl.org/sig/ont/fma/fma84050
T77 6717-6721 Body_part denotes hand http://purl.org/sig/ont/fma/fma9712

LitCovid-PD-UBERON

Id Subject Object Predicate Lexical cue uberon_id
T1 340-345 Body_part denotes organ http://purl.obolibrary.org/obo/UBERON_0000062
T2 544-548 Body_part denotes lung http://purl.obolibrary.org/obo/UBERON_0002048
T3 558-569 Body_part denotes endothelium http://purl.obolibrary.org/obo/UBERON_0001986
T4 631-636 Body_part denotes heart http://purl.obolibrary.org/obo/UBERON_0000948
T5 638-643 Body_part denotes liver http://purl.obolibrary.org/obo/UBERON_0002107
T6 1739-1744 Body_part denotes heart http://purl.obolibrary.org/obo/UBERON_0000948
T7 1746-1751 Body_part denotes liver http://purl.obolibrary.org/obo/UBERON_0002107
T8 1756-1762 Body_part denotes kidney http://purl.obolibrary.org/obo/UBERON_0002113
T9 1853-1858 Body_part denotes organ http://purl.obolibrary.org/obo/UBERON_0000062
T10 2758-2763 Body_part denotes serum http://purl.obolibrary.org/obo/UBERON_0001977
T11 2816-2820 Body_part denotes lung http://purl.obolibrary.org/obo/UBERON_0002048
T12 2861-2866 Body_part denotes serum http://purl.obolibrary.org/obo/UBERON_0001977
T13 2904-2908 Body_part denotes vein http://purl.obolibrary.org/obo/UBERON_0001638
T14 3741-3747 Body_part denotes myelin http://purl.obolibrary.org/obo/UBERON_0000345
T15 4538-4547 Body_part denotes extension http://purl.obolibrary.org/obo/UBERON_2000106
T16 4635-4641 Body_part denotes tissue http://purl.obolibrary.org/obo/UBERON_0000479
T17 4853-4858 Body_part denotes brain http://purl.obolibrary.org/obo/UBERON_0000955
T18 5365-5369 Body_part denotes lung http://purl.obolibrary.org/obo/UBERON_0002048
T19 5691-5697 Body_part denotes myelin http://purl.obolibrary.org/obo/UBERON_0000345
T20 6103-6112 Body_part denotes extension http://purl.obolibrary.org/obo/UBERON_2000106
T21 6717-6721 Body_part denotes hand http://purl.obolibrary.org/obo/UBERON_0002398

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T1 34-42 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T2 111-119 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T3 121-129 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T4 121-125 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T5 286-321 Disease denotes acute respiratory distress syndrome http://purl.obolibrary.org/obo/MONDO_0006502
T6 292-321 Disease denotes respiratory distress syndrome http://purl.obolibrary.org/obo/MONDO_0009971
T7 323-327 Disease denotes ARDS http://purl.obolibrary.org/obo/MONDO_0006502
T8 726-734 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T9 774-807 Disease denotes severe acute respiratory syndrome http://purl.obolibrary.org/obo/MONDO_0005091
T10 809-813 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T11 1004-1012 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T12 1004-1008 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T13 1353-1362 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T14 1688-1707 Disease denotes respiratory failure http://purl.obolibrary.org/obo/MONDO_0021113
T15 1818-1826 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T16 1818-1822 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T17 1847-1866 Disease denotes multi-organ failure http://purl.obolibrary.org/obo/MONDO_0043726
T18 1948-1956 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T19 2143-2149 Disease denotes asthma http://purl.obolibrary.org/obo/MONDO_0004979
T20 2157-2194 Disease denotes chronic obstructive pulmonary disease http://purl.obolibrary.org/obo/MONDO_0005002
T21 2177-2194 Disease denotes pulmonary disease http://purl.obolibrary.org/obo/MONDO_0005275
T22 2196-2200 Disease denotes COPD http://purl.obolibrary.org/obo/MONDO_0005002
T23 2821-2833 Disease denotes inflammation http://purl.obolibrary.org/obo/MONDO_0021166
T24 3010-3018 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T25 3033-3037 Disease denotes ARDS http://purl.obolibrary.org/obo/MONDO_0006502
T26 4729-4746 Disease denotes neuroinflammation http://purl.obolibrary.org/obo/MONDO_0004466
T27 4785-4803 Disease denotes multiple sclerosis http://purl.obolibrary.org/obo/MONDO_0005301
T28 4805-4811 Disease denotes stroke http://purl.obolibrary.org/obo/MONDO_0005098|http://purl.obolibrary.org/obo/MONDO_0011057
T30 4853-4865 Disease denotes brain injury http://purl.obolibrary.org/obo/MONDO_0043510
T31 4859-4865 Disease denotes injury http://purl.obolibrary.org/obo/MONDO_0021178
T32 5076-5084 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T33 5076-5080 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T34 5365-5377 Disease denotes lung fibroma http://purl.obolibrary.org/obo/MONDO_0021531
T35 5370-5377 Disease denotes fibroma http://purl.obolibrary.org/obo/MONDO_0005167
T36 5482-5490 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T37 5505-5509 Disease denotes ARDS http://purl.obolibrary.org/obo/MONDO_0006502
T38 5591-5599 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T39 5591-5595 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T40 6269-6277 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T41 6388-6391 Disease denotes flu http://purl.obolibrary.org/obo/MONDO_0005812
T42 6438-6448 Disease denotes infections http://purl.obolibrary.org/obo/MONDO_0005550
T43 6627-6635 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T44 6658-6662 Disease denotes ARDS http://purl.obolibrary.org/obo/MONDO_0006502
T45 7209-7216 Disease denotes Allergy http://purl.obolibrary.org/obo/MONDO_0005271
T46 7221-7231 Disease denotes Infectious http://purl.obolibrary.org/obo/MONDO_0005550
T47 7695-7698 Disease denotes Drs http://purl.obolibrary.org/obo/MONDO_0024265

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T1 340-345 http://purl.obolibrary.org/obo/UBERON_0003103 denotes organ
T2 426-436 http://purl.obolibrary.org/obo/CLO_0001658 denotes activation
T3 494-495 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T4 544-548 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
T5 544-548 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lung
T6 558-569 http://purl.obolibrary.org/obo/UBERON_0001986 denotes endothelium
T7 631-636 http://purl.obolibrary.org/obo/UBERON_0000948 denotes heart
T8 631-636 http://purl.obolibrary.org/obo/UBERON_0007100 denotes heart
T9 631-636 http://purl.obolibrary.org/obo/UBERON_0015228 denotes heart
T10 631-636 http://www.ebi.ac.uk/efo/EFO_0000815 denotes heart
T11 638-643 http://purl.obolibrary.org/obo/UBERON_0002107 denotes liver
T12 638-643 http://www.ebi.ac.uk/efo/EFO_0000887 denotes liver
T13 648-655 http://purl.obolibrary.org/obo/UBERON_0002113 denotes kidneys
T14 648-655 http://www.ebi.ac.uk/efo/EFO_0000927 denotes kidneys
T15 648-655 http://www.ebi.ac.uk/efo/EFO_0000929 denotes kidneys
T16 882-888 http://purl.obolibrary.org/obo/CLO_0001302 denotes 3], [4
T17 1015-1020 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T18 1038-1048 http://purl.obolibrary.org/obo/CL_0000066 denotes epithelial
T19 1049-1054 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T20 1168-1178 http://purl.obolibrary.org/obo/CLO_0001658 denotes activation
T21 1258-1260 http://purl.obolibrary.org/obo/CLO_0001562 denotes A2
T22 1307-1317 http://purl.obolibrary.org/obo/CLO_0001658 denotes activating
T23 1382-1392 http://purl.obolibrary.org/obo/CLO_0001658 denotes activation
T24 1485-1489 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T25 1490-1500 http://purl.obolibrary.org/obo/CLO_0001658 denotes activation
T26 1519-1523 http://purl.obolibrary.org/obo/PR_000001379 denotes IL-2
T27 1538-1543 http://purl.obolibrary.org/obo/PR_000005932 denotes G-CSF
T28 1582-1594 http://purl.obolibrary.org/obo/CLO_0009985 denotes This focused
T29 1644-1649 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lungs
T30 1739-1744 http://purl.obolibrary.org/obo/UBERON_0000948 denotes heart
T31 1739-1744 http://purl.obolibrary.org/obo/UBERON_0007100 denotes heart
T32 1739-1744 http://purl.obolibrary.org/obo/UBERON_0015228 denotes heart
T33 1739-1744 http://www.ebi.ac.uk/efo/EFO_0000815 denotes heart
T34 1746-1751 http://purl.obolibrary.org/obo/UBERON_0002107 denotes liver
T35 1746-1751 http://www.ebi.ac.uk/efo/EFO_0000887 denotes liver
T36 1756-1762 http://purl.obolibrary.org/obo/UBERON_0002113 denotes kidney
T37 1756-1762 http://www.ebi.ac.uk/efo/EFO_0000927 denotes kidney
T38 1756-1762 http://www.ebi.ac.uk/efo/EFO_0000929 denotes kidney
T39 1763-1768 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T40 1853-1858 http://purl.obolibrary.org/obo/UBERON_0003103 denotes organ
T41 2254-2260 http://purl.obolibrary.org/obo/UBERON_0001005 denotes airway
T42 2268-2274 http://purl.obolibrary.org/obo/UBERON_0001630 denotes muscle
T43 2268-2274 http://purl.obolibrary.org/obo/UBERON_0005090 denotes muscle
T44 2268-2274 http://www.ebi.ac.uk/efo/EFO_0000801 denotes muscle
T45 2268-2274 http://www.ebi.ac.uk/efo/EFO_0001949 denotes muscle
T46 2429-2439 http://purl.obolibrary.org/obo/CLO_0001658 denotes activating
T47 2471-2475 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T48 2504-2505 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T49 2649-2650 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T50 2788-2794 http://purl.obolibrary.org/obo/UBERON_0001005 denotes airway
T51 2816-2820 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
T52 2816-2820 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lung
T53 2841-2845 http://purl.obolibrary.org/obo/OGG_0000000002 denotes gene
T54 2904-2908 http://purl.obolibrary.org/obo/UBERON_0001638 denotes vein
T55 2904-2908 http://www.ebi.ac.uk/efo/EFO_0000816 denotes vein
T56 3148-3152 http://purl.obolibrary.org/obo/PR_000001379 denotes IL-2
T57 3399-3407 http://purl.obolibrary.org/obo/CLO_0001658 denotes activity
T58 3427-3428 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T59 3732-3739 http://purl.obolibrary.org/obo/PR_000018263 denotes peptide
T60 3765-3769 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T61 3793-3795 http://purl.obolibrary.org/obo/CLO_0001000 denotes 35
T62 3799-3806 http://purl.obolibrary.org/obo/PR_000018263 denotes peptide
T63 3878-3885 http://purl.obolibrary.org/obo/PR_000018263 denotes peptide
T64 3936-3942 http://purl.obolibrary.org/obo/CL_0000084 denotes T cell
T65 4145-4152 http://purl.obolibrary.org/obo/PR_000018263 denotes peptide
T66 4218-4225 http://purl.obolibrary.org/obo/CL_0000084 denotes T cells
T67 4258-4263 http://purl.obolibrary.org/obo/NCBITaxon_9606 denotes human
T68 4271-4272 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T69 4446-4451 http://purl.obolibrary.org/obo/NCBITaxon_9606 denotes human
T70 4524-4526 http://purl.obolibrary.org/obo/CLO_0001000 denotes 35
T71 4530-4537 http://purl.obolibrary.org/obo/PR_000018263 denotes peptide
T72 4662-4665 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T73 4694-4696 http://purl.obolibrary.org/obo/CLO_0001000 denotes 35
T74 4768-4774 http://purl.obolibrary.org/obo/NCBITaxon_33208 denotes animal
T75 4853-4858 http://purl.obolibrary.org/obo/UBERON_0000955 denotes brain
T76 4853-4858 http://www.ebi.ac.uk/efo/EFO_0000302 denotes brain
T77 4908-4910 http://purl.obolibrary.org/obo/CLO_0053733 denotes 11
T78 5149-5159 http://purl.obolibrary.org/obo/CLO_0001658 denotes activation
T79 5168-5172 http://purl.obolibrary.org/obo/PR_000001379 denotes IL-2
T80 5246-5247 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T81 5291-5300 http://purl.obolibrary.org/obo/CLO_0001658 denotes activated
T82 5309-5315 http://purl.obolibrary.org/obo/CL_0000084 denotes T cell
T83 5365-5369 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
T84 5365-5369 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lung
T85 5418-5426 http://purl.obolibrary.org/obo/CLO_0001658 denotes activity
T86 5467-5468 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T87 5523-5533 http://purl.obolibrary.org/obo/CLO_0001658 denotes activities
T88 5611-5612 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T89 5685-5690 http://purl.obolibrary.org/obo/NCBITaxon_9606 denotes human
T90 5715-5719 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T91 5739-5741 http://purl.obolibrary.org/obo/CLO_0001000 denotes 35
T92 5745-5752 http://purl.obolibrary.org/obo/PR_000018263 denotes peptide
T93 5814-5820 http://purl.obolibrary.org/obo/CL_0000084 denotes T cell
T94 6089-6091 http://purl.obolibrary.org/obo/CLO_0001000 denotes 35
T95 6095-6102 http://purl.obolibrary.org/obo/PR_000018263 denotes peptide
T96 6231-6232 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T97 6367-6370 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T98 6392-6397 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T99 6707-6708 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T100 6752-6756 http://purl.obolibrary.org/obo/CLO_0009609 denotes wish
T101 7695-7698 http://purl.obolibrary.org/obo/CLO_0002819 denotes Drs
T102 7747-7748 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T103 7818-7819 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T104 7842-7843 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T105 7948-7951 http://purl.obolibrary.org/obo/CLO_0051582 denotes has

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T1 571-577 Chemical denotes oxygen http://purl.obolibrary.org/obo/CHEBI_25805
T2 931-942 Chemical denotes angiotensin http://purl.obolibrary.org/obo/CHEBI_48433
T3 991-998 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T4 1213-1229 Chemical denotes arachidonic acid http://purl.obolibrary.org/obo/CHEBI_15843
T5 1225-1229 Chemical denotes acid http://purl.obolibrary.org/obo/CHEBI_37527
T6 1246-1260 Chemical denotes thromboxane A2 http://purl.obolibrary.org/obo/CHEBI_15627|http://purl.obolibrary.org/obo/CHEBI_57445
T8 1246-1257 Chemical denotes thromboxane http://purl.obolibrary.org/obo/CHEBI_26995
T9 1278-1280 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T11 1285-1287 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T13 1298-1324 Chemical denotes platelet activating factor http://purl.obolibrary.org/obo/CHEBI_52450
T14 1327-1339 Chemical denotes nitric oxide http://purl.obolibrary.org/obo/CHEBI_16480
T15 1334-1339 Chemical denotes oxide http://purl.obolibrary.org/obo/CHEBI_25741|http://purl.obolibrary.org/obo/CHEBI_29356
T17 1440-1442 Chemical denotes O2 http://purl.obolibrary.org/obo/CHEBI_15379
T18 1443-1451 Chemical denotes radicals http://purl.obolibrary.org/obo/CHEBI_26519
T19 1519-1521 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T21 1525-1527 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T23 1910-1925 Chemical denotes glucocorticoids http://purl.obolibrary.org/obo/CHEBI_24261
T24 1986-1990 Chemical denotes drug http://purl.obolibrary.org/obo/CHEBI_23888
T25 2106-2111 Chemical denotes drugs http://purl.obolibrary.org/obo/CHEBI_23888
T26 2236-2244 Chemical denotes agonists http://purl.obolibrary.org/obo/CHEBI_48705
T27 2312-2323 Chemical denotes antagonists http://purl.obolibrary.org/obo/CHEBI_48706
T28 2333-2335 Chemical denotes M3 http://purl.obolibrary.org/obo/CHEBI_51083|http://purl.obolibrary.org/obo/CHEBI_53453
T30 2368-2372 Chemical denotes drug http://purl.obolibrary.org/obo/CHEBI_23888
T31 2420-2446 Chemical denotes platelet-activating factor http://purl.obolibrary.org/obo/CHEBI_36707|http://purl.obolibrary.org/obo/CHEBI_44811|http://purl.obolibrary.org/obo/CHEBI_52450
T34 2451-2460 Chemical denotes histamine http://purl.obolibrary.org/obo/CHEBI_18295|http://purl.obolibrary.org/obo/CHEBI_58432
T36 2512-2534 Chemical denotes anti-inflammatory drug http://purl.obolibrary.org/obo/CHEBI_35472
T37 2530-2534 Chemical denotes drug http://purl.obolibrary.org/obo/CHEBI_23888
T38 2547-2557 Chemical denotes antagonist http://purl.obolibrary.org/obo/CHEBI_48706
T39 2566-2577 Chemical denotes thromboxane http://purl.obolibrary.org/obo/CHEBI_26995
T40 2591-2600 Chemical denotes cysteinyl http://purl.obolibrary.org/obo/CHEBI_23511|http://purl.obolibrary.org/obo/CHEBI_32460
T42 2601-2624 Chemical denotes leukotriene antagonists http://purl.obolibrary.org/obo/CHEBI_49159
T43 2601-2612 Chemical denotes leukotriene http://purl.obolibrary.org/obo/CHEBI_25029
T44 2613-2624 Chemical denotes antagonists http://purl.obolibrary.org/obo/CHEBI_48706
T45 2639-2647 Chemical denotes molecule http://purl.obolibrary.org/obo/CHEBI_25367
T46 2706-2708 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T48 2715-2717 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T50 2735-2737 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T52 2772-2774 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T54 3125-3127 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T56 3139-3141 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T58 3148-3150 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T60 3311-3321 Chemical denotes inhibitors http://purl.obolibrary.org/obo/CHEBI_35222
T61 3460-3464 Chemical denotes drug http://purl.obolibrary.org/obo/CHEBI_23888
T62 3619-3621 Chemical denotes DR http://purl.obolibrary.org/obo/CHEBI_73445
T63 3644-3654 Chemical denotes amino acid http://purl.obolibrary.org/obo/CHEBI_33709
T64 3644-3649 Chemical denotes amino http://purl.obolibrary.org/obo/CHEBI_46882
T65 3650-3654 Chemical denotes acid http://purl.obolibrary.org/obo/CHEBI_37527
T66 3732-3739 Chemical denotes peptide http://purl.obolibrary.org/obo/CHEBI_16670
T67 3770-3782 Chemical denotes glycoprotein http://purl.obolibrary.org/obo/CHEBI_17089
T68 3799-3806 Chemical denotes peptide http://purl.obolibrary.org/obo/CHEBI_16670
T69 3859-3861 Chemical denotes II http://purl.obolibrary.org/obo/CHEBI_74067
T70 3878-3885 Chemical denotes peptide http://purl.obolibrary.org/obo/CHEBI_16670
T71 4030-4037 Chemical denotes ligands http://purl.obolibrary.org/obo/CHEBI_52214
T72 4062-4070 Chemical denotes agonists http://purl.obolibrary.org/obo/CHEBI_48705
T73 4145-4152 Chemical denotes peptide http://purl.obolibrary.org/obo/CHEBI_16670
T74 4201-4208 Chemical denotes antigen http://purl.obolibrary.org/obo/CHEBI_59132
T75 4452-4454 Chemical denotes DR http://purl.obolibrary.org/obo/CHEBI_73445
T76 4493-4495 Chemical denotes DR http://purl.obolibrary.org/obo/CHEBI_73445
T77 4530-4537 Chemical denotes peptide http://purl.obolibrary.org/obo/CHEBI_16670
T78 4685-4687 Chemical denotes DR http://purl.obolibrary.org/obo/CHEBI_73445
T79 4813-4828 Chemical denotes methamphetamine http://purl.obolibrary.org/obo/CHEBI_6809
T80 5161-5163 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T82 5168-5170 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T84 5174-5176 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T86 5260-5262 Chemical denotes DP http://purl.obolibrary.org/obo/CHEBI_137245
T87 5347-5356 Chemical denotes beryllium http://purl.obolibrary.org/obo/CHEBI_30501|http://purl.obolibrary.org/obo/CHEBI_33783
T89 5626-5630 Chemical denotes drug http://purl.obolibrary.org/obo/CHEBI_23888
T90 5652-5654 Chemical denotes DR http://purl.obolibrary.org/obo/CHEBI_73445
T91 5720-5732 Chemical denotes glycoprotein http://purl.obolibrary.org/obo/CHEBI_17089
T92 5745-5752 Chemical denotes peptide http://purl.obolibrary.org/obo/CHEBI_16670
T93 6034-6036 Chemical denotes DR http://purl.obolibrary.org/obo/CHEBI_73445
T94 6095-6102 Chemical denotes peptide http://purl.obolibrary.org/obo/CHEBI_16670
T95 6181-6191 Chemical denotes inhibitors http://purl.obolibrary.org/obo/CHEBI_35222
T96 7994-7996 Chemical denotes VA http://purl.obolibrary.org/obo/CHEBI_75008

LitCovid-PD-HP

Id Subject Object Predicate Lexical cue hp_id
T4 1688-1707 Phenotype denotes respiratory failure http://purl.obolibrary.org/obo/HP_0002878
T1 292-312 Phenotype denotes respiratory distress http://purl.obolibrary.org/obo/HP_0002098
T2 496-510 Phenotype denotes cytokine storm http://purl.obolibrary.org/obo/HP_0033041
T3 860-866 Phenotype denotes sepsis http://purl.obolibrary.org/obo/HP_0100806
T5 2143-2149 Phenotype denotes asthma http://purl.obolibrary.org/obo/HP_0002099
T6 2157-2194 Phenotype denotes chronic obstructive pulmonary disease http://purl.obolibrary.org/obo/HP_0006510
T7 2196-2200 Phenotype denotes COPD http://purl.obolibrary.org/obo/HP_0006510
T8 2788-2814 Phenotype denotes airway hyperresponsiveness http://purl.obolibrary.org/obo/HP_0032933
T9 2992-3006 Phenotype denotes cytokine storm http://purl.obolibrary.org/obo/HP_0033041
T10 3325-3339 Phenotype denotes cytokine storm http://purl.obolibrary.org/obo/HP_0033041
T11 4805-4811 Phenotype denotes stroke http://purl.obolibrary.org/obo/HP_0001297
T12 5087-5101 Phenotype denotes cytokine storm http://purl.obolibrary.org/obo/HP_0033041
T13 5365-5377 Phenotype denotes lung fibroma http://purl.obolibrary.org/obo/HP_0010616
T14 5564-5578 Phenotype denotes Cytokine Storm http://purl.obolibrary.org/obo/HP_0033041
T15 5998-6012 Phenotype denotes Cytokine Storm http://purl.obolibrary.org/obo/HP_0033041
T16 6166-6180 Phenotype denotes cytokine storm http://purl.obolibrary.org/obo/HP_0033041
T17 6471-6477 Phenotype denotes sepsis http://purl.obolibrary.org/obo/HP_0100806
T18 7209-7216 Phenotype denotes Allergy http://purl.obolibrary.org/obo/HP_0012393

LitCovid-PD-GO-BP

Id Subject Object Predicate Lexical cue
T1 1071-1089 http://purl.obolibrary.org/obo/GO_0006956 denotes complement cascade
T2 1132-1152 http://purl.obolibrary.org/obo/GO_0070527 denotes platelet aggregation
T3 1157-1178 http://purl.obolibrary.org/obo/GO_0042116 denotes macrophage activation
T4 1265-1274 http://purl.obolibrary.org/obo/GO_0046903 denotes secretion
T5 1298-1317 http://purl.obolibrary.org/obo/GO_0030168 denotes platelet activating
T6 1371-1392 http://purl.obolibrary.org/obo/GO_0042119 denotes neutrophil activation
T7 1485-1500 http://purl.obolibrary.org/obo/GO_0001775 denotes cell activation
T8 1506-1515 http://purl.obolibrary.org/obo/GO_0046903 denotes secretion
T9 2420-2439 http://purl.obolibrary.org/obo/GO_0030168 denotes platelet-activating
T10 2476-2485 http://purl.obolibrary.org/obo/GO_0046903 denotes secretion
T11 2821-2833 http://purl.obolibrary.org/obo/GO_0006954 denotes inflammation
T12 2841-2856 http://purl.obolibrary.org/obo/GO_0010467 denotes gene expression
T13 3182-3202 http://purl.obolibrary.org/obo/GO_1905517 denotes macrophage migration
T14 4231-4242 http://purl.obolibrary.org/obo/GO_0006412 denotes translation
T15 4946-4956 http://purl.obolibrary.org/obo/GO_0065007 denotes regulation
T16 5022-5047 http://purl.obolibrary.org/obo/GO_0002250 denotes adaptive immune responses
T17 5140-5159 http://purl.obolibrary.org/obo/GO_0030168 denotes platelet activation

LitCovid-PD-GlycoEpitope

Id Subject Object Predicate Lexical cue glyco_epitope_db_id
T1 3789-3795 GlycoEpitope denotes MOG-35 http://www.glycoepitope.jp/epitopes/AN0706
T2 4520-4526 GlycoEpitope denotes MOG-35 http://www.glycoepitope.jp/epitopes/AN0706
T3 4690-4696 GlycoEpitope denotes MOG-35 http://www.glycoepitope.jp/epitopes/AN0706
T4 6085-6091 GlycoEpitope denotes MOG-35 http://www.glycoepitope.jp/epitopes/AN0706

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T1 0-20 Sentence denotes Surviving the storm:
T2 21-42 Sentence denotes Dealing with COVID-19
T3 44-364 Sentence denotes Although most of the 4.7 million individuals infected to date with COVID-19 (SARS-CoV-2) worldwide remain asymptomatic or have transient symptoms followed by complete recovery, approximately 316 thousand (6.7%) have died [1], most often from acute respiratory distress syndrome (ARDS) leading to organ failure and death.
T4 365-656 Sentence denotes The components that contribute to morbidity include forceful activation of both innate and adaptive immune pathways that release a cytokine storm which causes extensive damage to lung alveolar endothelium, oxygen insufficiency and downstream bystander damage to the heart, liver and kidneys.
T5 657-890 Sentence denotes Recent publications predicted immunological processes anticipated in COVID-19 patients based on previous findings in severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MARS) and sepsis patients [2], [3], [4].
T6 891-1340 Sentence denotes To reiterate, upon binding to the ACE2 (angiotensin-converting enzyme-2) receptor via its spike (S) protein, the SARS-CoV-2 virus infects alveolar epithelial cells, triggering the complement cascade and inducing fibrin deposition leading to platelet aggregation and macrophage activation resulting in metabolic changes in arachidonic acid with release of thromboxane A2 and secretion of IL-1β, IL-6, TNF-α, platelet activating factor & nitric oxide.
T7 1341-1581 Sentence denotes In addition infection induces neutrophil activation, aggregation and degranulation with release of O2 radicals and proteases and CCR4+CCR6+Th17 cell activation with secretion of IL-2, IL-7, IFN-γ, G-CSF and chemokines CCL2, CCL3 and CXCl10.
T8 1582-1708 Sentence denotes This focused collection of highly inflammatory factors in the lungs causes serious endothelial damage and respiratory failure.
T9 1709-1867 Sentence denotes As well, ACE2 is expressed on heart, liver and kidney cells that may also be infected and gravely damaged by SARS-CoV-2, leading to fatal multi-organ failure.
T10 1868-2051 Sentence denotes In addition to current approaches such as glucocorticoids for treating advanced COVID-19 patients, there may be other drug combinations that could be helpful, some being bifunctional.
T11 2052-2346 Sentence denotes As relevant examples reviewed in [5], pharmacological drugs for treatment of patients with asthma and/or chronic obstructive pulmonary disease (COPD) were developed to include both β2-agonists to relax airway smooth muscle constriction and muscarinic receptor antagonists to block M3 receptors.
T12 2347-2503 Sentence denotes Another bifunctional drug was formulated to antagonize the receptors for platelet-activating factor and histamine, and mast cell secretion-blocking effects.
T13 2504-2648 Sentence denotes A third anti-inflammatory drug combined an antagonist for the thromboxane receptor and cysteinyl-leukotriene antagonists into the same molecule.
T14 2649-2895 Sentence denotes A bifunctional antibody construct was also developed for IL-4 and IL-13 to reduce the IL-4-dependent rise in serum IgE and IL-13-dependent airway hyperresponsiveness, lung inflammation, mucin gene expression and serum chitinase responses in mice.
T15 2896-3060 Sentence denotes In this vein, bifunctional immunotherapeutic approaches could be developed for treatment of the cytokine storm in COVID-19 patients with ARDS at high risk of death.
T16 3061-3408 Sentence denotes Proven and developing therapies that downregulate receptors for IL-1β, TNF-α, IL-6 and IL-2 as well as those which block macrophage migration inhibitory factor (MIF) and its homolog MIF2 through CD74 and potentially CXCR2&4 for MIF are all potential inhibitors of cytokine storm effects and could be combined or designed for bifunctional activity.
T17 3409-3589 Sentence denotes We are developing a second generation bifunctional drug called DRhQ that can simultaneously bind to and inhibit both the TCR and CD74 through distinct regions of the construct [6].
T18 3590-3818 Sentence denotes DRhQ is comprised of the HLA-DRα1 domain with an L50Q amino acid substitution (to enhance binding affinity for CD74) linked to an autoantigen peptide (myelin oligodendroglial cell glycoprotein, i.e. MOG-35-55 peptide) (Fig. 1 ).
T19 3819-4046 Sentence denotes DRhQ was derived from soluble MHC Class II α1-β1-antigenic peptide constructs originally designed to ligate specific T cell receptors as the distal components of the trimolecular complex (called Recombinant TCR ligands – RTLs).
T20 4047-4366 Sentence denotes As partial TCR agonists these constructs, containing various disease-associated MHC and antigenic peptide components, could indeed inhibit MHC-restricted antigen specific T cells, but translation of RTL1000 for human use in a Phase 1 clinical trial (showing safety and tolerability) required MHC-matched recipients [7].
T21 4367-4656 Sentence denotes Thus, the simpler DRhQ construct was designed, retaining just the conserved-in-human DRα1 domain (without the polymorphic HLA-DRβ1 domain) linked to the MOG-35-55 peptide extension, with the added benefit that it can be administered to all recipients without need for tissue type matching.
T22 4657-4870 Sentence denotes This has enabled use of the DRα1-MOG-35-55 construct to reverse ongoing neuroinflammation and disease signs in animal models of multiple sclerosis, stroke, methamphetamine disorders and traumatic brain injury [8].
T23 4871-5222 Sentence denotes These and other studies ([9], [10], [11] & unpublished data) revealed down-regulation of multiple proinflammatory components driven by both innate and adaptive immune responses that also contribute to the SARS-CoV-2 cytokine storm, including complement receptor C5aR1, platelet activation, IL-1β, IL-2, IL-6, TNF-α, CCR2 (receptor for CCL2) and CXCR2.
T24 5223-5510 Sentence denotes Of further importance, a partial HLA-DP RTL construct could inhibit activated pleural T cell infiltrates from patients with beryllium-induced lung fibroma [12], suggesting more-directly-relevant activity that could be potentially beneficial as a treatment of COVID-19 patients with ARDS.
T25 5511-5602 Sentence denotes Fig. 1 Dual activities of DRhQ that could block the “Cytokine Storm” induced by SARS-CoV-2.
T26 5603-5753 Sentence denotes DRhQ is a bifunctional drug comprised of the HLA-DRα1 domain covalently linked to human myelin oligodendroglial cell glycoprotein (MOG)-35-55 peptide.
T27 5754-6013 Sentence denotes Due to its unique design, DRhQ can bind to and inhibit both T cell receptors and the MHC “invariant” chain, CD74, that serves as the receptor for the proinflammatory homologs, MIF and MIF2, resulting in blockade of multiple contributors to the Cytokine Storm.
T28 6014-6025 Sentence denotes DRhQ image:
T29 6026-6113 Sentence denotes Green = DRα1L50Q domain; Dark green line = linker; Black = MOG-35-55 peptide extension.
T30 6114-6222 Sentence denotes Development of new generation immunologically based cytokine storm inhibitors remains an important endeavor.
T31 6223-6478 Sentence denotes Even if a successful vaccine is developed for COVID-19 patients, there will be ongoing mortality in vulnerable populations after vaccination as has been observed in flu virus and other current or future coronavirus infections as well as those with sepsis.
T32 6479-6663 Sentence denotes In these conditions, resolution or chronicity of disease depends upon the strength of regulatory immune processes which appear to be compromised in COVID-19 patients that develop ARDS.
T33 6664-6722 Sentence denotes To this end, the DRhQ construct could lend a helping hand.
T34 6724-6739 Sentence denotes Acknowledgement
T35 6740-6842 Sentence denotes The authors wish to thank Ashley Headrick for help in preparing and submitting the commentary article.
T36 6844-6851 Sentence denotes Funding
T37 6852-7265 Sentence denotes This work was funded by the 10.13039/100000738Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development Merit Review Awards 2I01 BX000226 and IMMA-010-19F (AAV), Senior Research Career Scientist Award 1IK6BX004209 (AAV) and the 10.13039/100000060National Institute of Allergy and Infectious Diseases award R44AI122574 (AAV).
T38 7266-7365 Sentence denotes The contents do not represent the views of the Department of Veterans Affairs or the US Government.
T39 7367-7401 Sentence denotes Availability of data and materials
T40 7402-7526 Sentence denotes The datasets used and/or analyzed during previous studies are available from the corresponding author on reasonable request.
T41 7528-7548 Sentence denotes Author contributions
T42 7549-7624 Sentence denotes The commentary article was written, edited and reviewed by AAV, HO and RMR.
T43 7625-7673 Sentence denotes All authors read and approved the final article.
T44 7675-7694 Sentence denotes Competing Interests
T45 7695-7911 Sentence denotes Drs. Vandenbark, Offner, Meza-Romero, and OHSU have a significant financial interest in Artielle ImmunoTherapeutics, Inc., a company that may have a commercial interest in the results of this research and technology.
T46 7912-8069 Sentence denotes This potential conflict of interest has been reviewed and managed by the OHSU and VA Portland Health Care System Conflict of Interest in Research Committees.

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id tao:has_standard_notation
1 34-42 Disease denotes COVID-19 MESH:C000657245
44 925-929 Gene denotes ACE2 Gene:59272
45 931-962 Gene denotes angiotensin-converting enzyme-2 Gene:59272
46 1278-1283 Gene denotes IL-1β Gene:3552
47 1285-1289 Gene denotes IL-6 Gene:3569
48 1291-1296 Gene denotes TNF-α Gene:7124
49 1470-1474 Gene denotes CCR4 Gene:1233
50 1475-1479 Gene denotes CCR6 Gene:1235
51 1519-1523 Gene denotes IL-2 Gene:3558
52 1525-1529 Gene denotes IL-7 Gene:3574
53 1531-1536 Gene denotes IFN-γ Gene:3458
54 1538-1543 Gene denotes G-CSF Gene:1440
55 1559-1563 Gene denotes CCL2 Gene:6347
56 1565-1569 Gene denotes CCL3 Gene:6348
57 1574-1580 Gene denotes CXCl10 Gene:3627
58 1718-1722 Gene denotes ACE2 Gene:59272
59 121-131 Species denotes SARS-CoV-2 Tax:2697049
60 735-743 Species denotes patients Tax:9606
61 867-875 Species denotes patients Tax:9606
62 1004-1014 Species denotes SARS-CoV-2 Tax:2697049
63 1818-1828 Species denotes SARS-CoV-2 Tax:2697049
64 1258-1260 Gene denotes A2 Gene:170589
65 571-577 Chemical denotes oxygen MESH:D010100
66 1213-1229 Chemical denotes arachidonic acid MESH:D016718
67 1327-1339 Chemical denotes nitric oxide MESH:D009569
68 1440-1442 Chemical denotes O2 MESH:D010100
69 89-97 Disease denotes infected MESH:D007239
70 111-119 Disease denotes COVID-19 MESH:C000657245
71 260-264 Disease denotes died MESH:D003643
72 286-321 Disease denotes acute respiratory distress syndrome MESH:D012128
73 323-327 Disease denotes ARDS MESH:D012128
74 340-353 Disease denotes organ failure MESH:D009102
75 358-363 Disease denotes death MESH:D003643
76 578-591 Disease denotes insufficiency MESH:D000309
77 726-734 Disease denotes COVID-19 MESH:C000657245
78 781-807 Disease denotes acute respiratory syndrome MESH:D012120
79 816-848 Disease denotes Middle East respiratory syndrome MESH:D018352
80 860-866 Disease denotes sepsis MESH:D018805
81 1132-1152 Disease denotes platelet aggregation MESH:D001791
82 1353-1362 Disease denotes infection MESH:D007239
83 1688-1707 Disease denotes respiratory failure MESH:D012131
84 1786-1794 Disease denotes infected MESH:D007239
85 1847-1866 Disease denotes multi-organ failure MESH:D009102
115 2233-2235 Gene denotes β2 Gene:170589
116 2706-2710 Gene denotes IL-4 Gene:16189
117 2715-2720 Gene denotes IL-13 Gene:16163
118 2735-2739 Gene denotes IL-4 Gene:16189
119 2772-2777 Gene denotes IL-13 Gene:16163
120 3125-3130 Gene denotes IL-1β Gene:3552
121 3132-3137 Gene denotes TNF-α Gene:7124
122 3139-3143 Gene denotes IL-6 Gene:3569
123 3148-3152 Gene denotes IL-2 Gene:3558
124 3182-3220 Gene denotes macrophage migration inhibitory factor Gene:4282
125 3222-3225 Gene denotes MIF Gene:4282
126 3243-3247 Gene denotes MIF2 Gene:1060
127 3277-3284 Gene denotes CXCR2&4 Gene:3579
128 3289-3292 Gene denotes MIF Gene:4282
129 1957-1965 Species denotes patients Tax:9606
130 2129-2137 Species denotes patients Tax:9606
131 2890-2894 Species denotes mice Tax:10090
132 3019-3027 Species denotes patients Tax:9606
133 2451-2460 Chemical denotes histamine MESH:D006632
134 2591-2612 Chemical denotes cysteinyl-leukotriene MESH:C112381
135 1948-1956 Disease denotes COVID-19 MESH:C000657245
136 2143-2149 Disease denotes asthma MESH:D001249
137 2157-2194 Disease denotes chronic obstructive pulmonary disease MESH:D029424
138 2196-2200 Disease denotes COPD MESH:D029424
139 2788-2814 Disease denotes airway hyperresponsiveness MESH:D000402
140 2816-2833 Disease denotes lung inflammation MESH:D011014
141 3010-3018 Disease denotes COVID-19 MESH:C000657245
142 3033-3037 Disease denotes ARDS MESH:D012128
143 3054-3059 Disease denotes death MESH:D003643
153 5691-5732 Gene denotes myelin oligodendroglial cell glycoprotein Gene:4340
154 5734-5737 Gene denotes MOG Gene:4340
155 5839-5842 Gene denotes MHC Gene:3107
156 5930-5933 Gene denotes MIF Gene:4282
157 5938-5942 Gene denotes MIF2 Gene:1060
158 6085-6088 Gene denotes MOG Gene:4340
159 5591-5601 Species denotes SARS-CoV-2 Tax:2697049
160 5685-5690 Species denotes human Tax:9606
161 5603-5607 Chemical denotes DRhQ
194 3741-3782 Gene denotes myelin oligodendroglial cell glycoprotein Gene:4340
195 3789-3792 Gene denotes MOG Gene:4340
196 4127-4130 Gene denotes MHC Gene:3107
197 4339-4342 Gene denotes MHC Gene:3107
198 5133-5138 Gene denotes C5aR1 Gene:728
199 5161-5166 Gene denotes IL-1β Gene:3552
200 5168-5172 Gene denotes IL-2 Gene:3558
201 5174-5178 Gene denotes IL-6 Gene:3569
202 5180-5185 Gene denotes TNF-α Gene:7124
203 5187-5191 Gene denotes CCR2 Gene:729230
204 5206-5210 Gene denotes CCL2 Gene:6347
205 5216-5221 Gene denotes CXCR2 Gene:3579
206 4690-4693 Gene denotes MOG Gene:4340
207 4520-4523 Gene denotes MOG Gene:4340
208 4258-4263 Species denotes human Tax:9606
209 4446-4451 Species denotes human Tax:9606
210 5076-5086 Species denotes SARS-CoV-2 Tax:2697049
211 5333-5341 Species denotes patients Tax:9606
212 5491-5499 Species denotes patients Tax:9606
213 4186-4189 Gene denotes MHC Gene:3107
214 3472-3476 Chemical denotes DRhQ
215 4813-4828 Chemical denotes methamphetamine MESH:D008694
216 5347-5356 Chemical denotes beryllium MESH:D001608
217 4729-4746 Disease denotes neuroinflammation MESH:D020078
218 4785-4803 Disease denotes multiple sclerosis MESH:D009103
219 4805-4811 Disease denotes stroke MESH:D020521
220 4843-4865 Disease denotes traumatic brain injury MESH:D000070642
221 5301-5310 Disease denotes pleural T MESH:D010995
222 5365-5377 Disease denotes lung fibroma MESH:D008171
223 5482-5490 Disease denotes COVID-19 MESH:C000657245
224 5505-5509 Disease denotes ARDS MESH:D012128
225 3639-3643 Mutation denotes L50Q p.L50Q
234 6278-6286 Species denotes patients Tax:9606
235 6636-6644 Species denotes patients Tax:9606
236 6269-6277 Disease denotes COVID-19 MESH:C000657245
237 6310-6319 Disease denotes mortality MESH:D003643
238 6426-6448 Disease denotes coronavirus infections MESH:D018352
239 6471-6477 Disease denotes sepsis MESH:D018805
240 6627-6635 Disease denotes COVID-19 MESH:C000657245
241 6658-6662 Disease denotes ARDS MESH:D012128